Reuters logo
BRIEF-Adocia Announces Positive Topline Study Results
December 6, 2017 / 5:40 PM / 7 days ago

BRIEF-Adocia Announces Positive Topline Study Results

Dec 6 (Reuters) - ADOCIA SA:

* ADOCIA ANNOUNCES POSITIVE TOPLINE STUDY RESULTS COMPARING ULTRA-RAPID INSULIN BIOCHAPERONE LISPRO WITH NOVOLOG AND FIASP IN PEOPLE WITH TYPE 1 DIABETES

* BIOCHAPERONE LISPRO U100 SHOWED A SIGNIFICANTLY FASTER-OFF EFFECT COMPARED TO FIASPAND SIMILAR ULTRA-RAPID ONSET OF ACTION

* BIOCHAPERONE LISPRO U100 DISPLAYED FASTER-ON AND FASTER-OFF METABOLIC EFFECTS COMPARED TO NOVOLOG Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below